Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)

This is a recording of a webinar aired on Monday, October 17, 2022 Speaker: Dr. Fred Appelbaum, Executive Vice President of Fred Hutch Cancer Center and Associate Director for Clinical Research at the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium.